These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 35055187)
1. Exosome-Based Treatment for Atherosclerosis. Heo J; Kang H Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055187 [TBL] [Abstract][Full Text] [Related]
2. Exosomes: An emerging factor in atherosclerosis. Wang Y; Xie Y; Zhang A; Wang M; Fang Z; Zhang J Biomed Pharmacother; 2019 Jul; 115():108951. PubMed ID: 31078042 [TBL] [Abstract][Full Text] [Related]
3. The Exosome-Derived Biomarker in Atherosclerosis and Its Clinical Application. Lu M; Yuan S; Li S; Li L; Liu M; Wan S J Cardiovasc Transl Res; 2019 Feb; 12(1):68-74. PubMed ID: 29802541 [TBL] [Abstract][Full Text] [Related]
4. Progression in the Relationship between Exosome Production and Atherosclerosis. Yang Y; Luo J; Kang Y; Wu W; Lu Y; Fu J; Zhang X; Cheng M; Cui X Curr Pharm Biotechnol; 2024; 25(9):1099-1111. PubMed ID: 37493161 [TBL] [Abstract][Full Text] [Related]
5. Challenges in Exosome Isolation and Analysis in Health and Disease. Ludwig N; Whiteside TL; Reichert TE Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546622 [TBL] [Abstract][Full Text] [Related]
6. Exosomes in Atherosclerosis, a Double-Edged Sword: Their Role in Disease Pathogenesis and Their Potential as Novel Therapeutics. Patel N; Chin DD; Chung EJ AAPS J; 2021 Jul; 23(5):95. PubMed ID: 34312734 [TBL] [Abstract][Full Text] [Related]
7. Exosomes in Cholesterol Metabolism and Atherosclerosis. Reiss AB; Vernice NA; Siegart NM; De Leon J; Kasselman LJ Cardiovasc Hematol Disord Drug Targets; 2017; 17(3):185-194. PubMed ID: 29299993 [TBL] [Abstract][Full Text] [Related]
8. The Role of Exosomes and Exosome-derived microRNAs in Atherosclerosis. Lu X Curr Pharm Des; 2017; 23(40):6182-6193. PubMed ID: 28412904 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Exosomes and MicroRNAs in Cardiovascular Physiology and Pathophysiology. Henning RJ J Cardiovasc Transl Res; 2021 Apr; 14(2):195-212. PubMed ID: 32588374 [TBL] [Abstract][Full Text] [Related]
10. Exosome-mediated delivery of inflammation-responsive Bu T; Li Z; Hou Y; Sun W; Zhang R; Zhao L; Wei M; Yang G; Yuan L Theranostics; 2021; 11(20):9988-10000. PubMed ID: 34815799 [No Abstract] [Full Text] [Related]
11. The role of exo-miRNA in diagnosis and treatment of cancers, focusing on effective miRNAs in colorectal cancer. Kzar Al-Shukri HH; Abdul-Jabbar Ali S; Al-Akkam KA; Hjazi A; Rasulova I; Mustafa YF; Al-Saidi DN; Alasheqi MQ; Alawadi A; Alsaalamy A Cell Biol Int; 2024 Mar; 48(3):280-289. PubMed ID: 38225535 [TBL] [Abstract][Full Text] [Related]
12. Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets. Wang C; Li Z; Liu Y; Yuan L Theranostics; 2021; 11(8):3996-4010. PubMed ID: 33664877 [TBL] [Abstract][Full Text] [Related]
13. Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation. Zhu J; Liu B; Wang Z; Wang D; Ni H; Zhang L; Wang Y Theranostics; 2019; 9(23):6901-6919. PubMed ID: 31660076 [No Abstract] [Full Text] [Related]
14. Methods to purify DNA from extracellular vesicles: Focus on exosomes. Spada S Methods Enzymol; 2020; 645():109-118. PubMed ID: 33565966 [TBL] [Abstract][Full Text] [Related]
15. Secretome from SH-SY5Y APP Fernandes A; Ribeiro AR; Monteiro M; Garcia G; Vaz AR; Brites D Biochimie; 2018 Dec; 155():67-82. PubMed ID: 29857185 [TBL] [Abstract][Full Text] [Related]
16. The emerging role of exosomes as novel therapeutics: Biology, technologies, clinical applications, and the next. Song Y; Kim Y; Ha S; Sheller-Miller S; Yoo J; Choi C; Park CH Am J Reprod Immunol; 2021 Feb; 85(2):e13329. PubMed ID: 32846024 [TBL] [Abstract][Full Text] [Related]
18. Recent advancements in the use of exosomes as drug delivery systems. Bunggulawa EJ; Wang W; Yin T; Wang N; Durkan C; Wang Y; Wang G J Nanobiotechnology; 2018 Oct; 16(1):81. PubMed ID: 30326899 [TBL] [Abstract][Full Text] [Related]
19. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901 [TBL] [Abstract][Full Text] [Related]